[The guidelines for diagnosis and treatment of myeloma bone disease in China (2022)]. [PDF]
Hematological Oncology Committee of China Anti-Cancer Association +2 more
europepmc +1 more source
[Prognostic value of circulating plasma cell in newly diagnosed multiple myeloma treated with bortezomib, lenalidomide, and dexamethasone]. [PDF]
Liu RR +6 more
europepmc +1 more source
[Multiple myeloma with chromothripsis: three cases report]. [PDF]
Wu CX +10 more
europepmc +1 more source
[The role and molecular mechanism of transcription factor EB and its target genes in multiple myeloma treatment with bortezomib]. [PDF]
Zhang RJ +8 more
europepmc +1 more source
[Effects of extramedullary disease on patients with newly diagnosed multiple myeloma]. [PDF]
Tao Y +8 more
europepmc +1 more source
A prognostic model for multiple myeloma based on lipid metabolism related genes. [PDF]
Li Z, Zhao L, Shi F, Guo J, Zhou W.
europepmc +1 more source
[Development, reliability, and validity of a treatment-related quality of life scale for Chinese patients with multiple myeloma]. [PDF]
Sun CY +30 more
europepmc +1 more source
Primary Pulmonary Extramedullary Plasmacytoma in 18F-FDG PET/CT Imaging: A Case Report and Review of Literature [PDF]
HU Xiaoyan +4 more
core +1 more source
[Research progress in targeting GPRC5D for the treatment of multiple myeloma]. [PDF]
An JY, Pan MM, Ouyang HY, Mi JQ.
europepmc +1 more source
[Chinese expert consensus on standard procedures for the outpatient management of patients with multiple myeloma (2025)]. [PDF]
Plasma Cell Disease Group +3 more
europepmc +1 more source

